Injective INJ
Current Price
$3.17 -3.16%
$0.1900 Daily Range (5.99%)
$3.15$3.34
$36.59M Daily Volume
518 BTC
Vol/MktCap: 11.54%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $36.59M over the past 24 hours, compared to $40.21B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.23 -2.00%
13 SMA $3.25 -2.48%
21 SMA $3.26 -2.80%
55 SMA $3.23 -1.92%
144 SMA $3.40 -6.83%
Price Performance
-1.32% 1 Hour Change
$3.17 from $3.21
-9.63% 7 Day Change
-$0.3053 from $3.48
-27.42% 14 Day Change
-$0.8694 from $4.04
-40.27% 30 Day Change
-$1.28 from $4.45
All Time High
March 14, 2024
$52.62 -93.97%
-$49.45 vs. now
24H Change
-10.36M USD -3.16%
-147 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
11.27M INJ
traded over past 24 hours
11.27% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.22, reflecting a modest 24-hour price increase of 1.67%. The daily range has been tight, with a high of $3.34 and a low of $3.15, suggesting consolidation within this price band.
Volume has reached approximately $47.27 million, translating to a Vol/Market Cap ratio of 14.72%, indicating a healthy level of trading activity relative to its market capitalization. However, the moving averages indicate a bearish trend in the short term, with the 8 SMA at $3.27 and declining, while the 55 SMA at $3.21 shows a slight positive momentum.
The 1-hour RSI stands at 43, suggesting the asset is nearing oversold territory, while the 7-day RSI at 45 confirms weak momentum in the short term. Price performance over the last week, 14 days, and 30 days has been notably negative, with declines of approximately 11.8%, 27.7%, and 37.4%, respectively.
Despite the recent uptick, the overall trend remains bearish, compounded by significant distance from the all-time high of $52.62 achieved earlier this year. Unless there are fundamental catalysts or a significant shift in market sentiment, the momentum indicators do not support a strong recovery at this time.
Based on this analysis, the recommendation for Injective (INJ) is to Hold. The current price action and moving averages suggest a lack of bullish momentum, and while a potential rebound could occur, it is not substantiated by the current technical indicators or price performance trends.
Volume has reached approximately $47.27 million, translating to a Vol/Market Cap ratio of 14.72%, indicating a healthy level of trading activity relative to its market capitalization. However, the moving averages indicate a bearish trend in the short term, with the 8 SMA at $3.27 and declining, while the 55 SMA at $3.21 shows a slight positive momentum.
The 1-hour RSI stands at 43, suggesting the asset is nearing oversold territory, while the 7-day RSI at 45 confirms weak momentum in the short term. Price performance over the last week, 14 days, and 30 days has been notably negative, with declines of approximately 11.8%, 27.7%, and 37.4%, respectively.
Despite the recent uptick, the overall trend remains bearish, compounded by significant distance from the all-time high of $52.62 achieved earlier this year. Unless there are fundamental catalysts or a significant shift in market sentiment, the momentum indicators do not support a strong recovery at this time.
Based on this analysis, the recommendation for Injective (INJ) is to Hold. The current price action and moving averages suggest a lack of bullish momentum, and while a potential rebound could occur, it is not substantiated by the current technical indicators or price performance trends.
Updated 430 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Odds of Jesus Christ appearing in 2026 double, beating return on bitcoin
The Polymarket bet is a reminder that the weirdest corners of crypto are sometimes the only ones going up.

Crypto retail investors are trying to 'meta-analyze' crypto crash: Santiment
Santiment said the increased use of “capitulation” among crypto users on social media could suggest the market bottom has already happened.

Samsung Electronics' HBM4 chip expected to begin shipping later this month
Samsung Electronics is expected to begin shipments of its next-generation high-bandwidth memory, HBM4, later this month.

India and Malaysia agree to combine chip design and manufacturing facilities in trade agreement
Indian Prime Minister Narendra Modi met with Malaysian leader Anwar Ibrahim in Putrajaya on Sunday to discuss deeper cooperation on computer chips and trade, marking his first…